Company: CI
Filing Date: 2025-10-30
Form Type: 10-Q
Source: 0001739940-25-000037
Chunk: 286

Company: Cigna Group
Filing Date: 2025-10-30
Form: 10-Q
Item: Part I, Item 4
Chunk 286
---
 $299.23 — $7,732 September 1 - 30, 20252,989 $290.74 — $7,732 Total6,500 $296.15 — N/A

(1)Includes shares tendered by employees under the Company's equity compensation plans as follows: 1) payment of taxes on vesting of restricted stock (grants and units) and strategic performance shares and 2) payment of the exercise price and taxes for certain stock options exercised. Employees tendered 1,109 shares in July, 2,402 shares in August and 2,989 shares in September 2025. 

(2)Additionally, the Company maintains a share repurchase program authorized by the Board. Under this program, the Company may repurchase shares from time to time, depending on market conditions and alternate uses of capital. The timing and actual number of shares repurchased will depend on a variety of factors, including price, general business and market conditions, and alternate uses of capital. The share repurchase program may be effected through Rule 10b5-1 plans, open market purchases, each in compliance with Rule 10b-18 under the Exchange Act, or privately negotiated transactions. The program may be suspended or discontinued at any time and does not have an expiration date.

(3)The average price paid per share and approximate dollar value of shares exclude the impact of excise tax.

Item 5. OTHER INFORMATION

Rule 10b5-1 Plan Elections 

During the three months ended September 30, 2025, no director or officer of the Company adopted, modified, or terminated a "Rule 10b5-1 trading arrangement" or "non-Rule 10b5-1 trading arrangement," as each term is defined in Item 408(a) of Regulation S-K.

49

Item 6. EXHIBITS

INDEX TO EXHIBITSNumberDescriptionMethod of Filing3.1Restated Certificate of Incorporation of The Cigna GroupFiled by the registrant as Exhibit 3.1 to the Quarterly Report on Form 10-Q for the period ended June 30, 2023 and incorporated herein by reference.3.2Amended and Restated By-laws of The Cigna GroupFiled by the registrant as Exhibit 3.3 to the Current Report on Form 8-K on February 13, 2023 and incorporated herein by reference.4